IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring ...
On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
It’s a baby (monitor) boom! Shortly after Owlet secured a long-awaited FDA clearance for its baby-monitoring “sock” equipped with pulse oximetry technology—which was followed just last month by ...
LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) ...
Masimo Corp. today announced a new study revealing the potential cost-savings for hospitals that use its technologies to continuously monitor patients. The findings, published in the Journal of ...
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. The medtech has tapped Katie Szyman for the role, who has been serving as the worldwide ...
Politan Capital Management has maintained a significant stake of around 9% in Masimo since 2022. Masimo expects the business separation to include its consumer audio and health products. Get the ...
Irvine-based Masimo Corp. said Tuesday that it has bought SedLine Inc., a medical device startup that it’s invested in. Terms of the deal weren’t disclosed. Masimo makes patient monitoring devices and ...
Danaher plans to complete its acquisition of Masimo (NasdaqGS:MASI) in the second half of the year. The deal is expected to affect Danaher's overall growth profile, with Masimo's bioprocessing ...
Danaher said Tuesday it has agreed to acquire patient monitoring company Masimo for $9.9 billion to bolster its diagnostics franchise. Masimo will become a standalone business unit and brand within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results